Abstract
The aim of this study was to examine the independent relationship between serum uric acid (SUA) and blood pressure, and to assess their joint effects on obesity, fasting glucose and lipids. The study samples were from a community-based health examination survey in Xuzhou, Jiangsu province of China (2009). Blood pressure, body mass index, fasting glucose, lipids and SUA were measured. After excluding individuals with fasting glucose greater than 7 mmol l−1, a total of 8415 subjects with biomarkers available were included in the present study. Blood pressure increased with elevated SUA levels, after adjusting for age and sex. Further adjustment for fasting glucose, lipids and alcohol consumption did not change the increasing trend. The associations between uric acid and hypertension were most evident in those with highest quintiles of high-density lipoprotein cholesterol (HDL-C). In addition, the associations were significant in both men and women, and we found significant interactions between uric acid status and age on hypertension. When the joint effects were examined, we found an additive effect of triglycerides and uric acid levels on diastolic blood pressure (DBP). There was significant association between SUA and hypertension, independent of other metabolic risk factors. HDL-C levels may modify the associations between uric acid and hypertension. The effects of triglycerides and uric acid levels on DBP were additive.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Forman JP, Choi H, Curhan GC . Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009; 169 (2): 155–162.
Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006; 48 (6): 1031–1036.
Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69 (8): 928–933.
Ishizaka N, Ishizaka Y, Toda E, Hashimoto H, Nagai R, Yamakado M . Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 2007; 192 (1): 131–137.
Chen JH, Chuang SY, Chen HJ, Yeh WT, Pan WH . Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009; 61 (2): 225–232.
Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN . Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008; 57 (6): 845–852.
Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenic link? J Am Soc Nephrol 2005; 16 (7): 1909–1919.
Coutinho T de A, Turner ST, Peyser PA, Bielak LF, Sheedy II PF, Kullo IJ . Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens 2007; 20 (1): 83–89.
Ouppatham S, Bancha S, Choovichian P . The relationship of hyperuricemia and blood pressure in the Thai army population. J Postgrad Med 2008; 54 (4): 259–262.
Forman JP, Choi H, Curhan GC . Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med 2009; 169 (2): 155–162.
Schachter M . Uric acid and hypertension. Curr Pharm Des 2005; 11 (32): 4139–4143.
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease. Hypertension 2003; 41 (6): 1183–1190.
Krishnan E, Kwoh CK, Schumacher HR, Kuller L . Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension 2007; 49 (2): 298–303.
Chen LY, Zhu WH, Chen ZW, Dai HL, Ren JJ, Chen JH et al. Relationship between hyperuricemia and metabolic syndrome. J Zhejiang Univ Sci B 2007; 8 (8): 593–598.
Coca A, Cea-Calvo L, Lozano JV, Inaraja V, Fernández-Pérez C, Navarro J et al. High-density lipoprotein cholesterol and cardiovascular disease in Spanish hypertensive women. The RIMHA study. Rev Esp Cardiol 2009; 62 (9): 1022–1031.
Mineo C, Deguchi H, Griffin JH, Shaul PW . Endothelial and antithrombotic actions of HDL. Circ Res 2006; 98 (11): 1352–1364.
Vekic J, Jelic-Ivanovic Z, Spasojevic-Kalimanovska V, Memon L, Zeljkovic A, Bogavac-Stanojevic N et al. High serum uric acid and low-grade inflammation are associated with smaller LDL-C and HDL-C particles. Atherosclerosis 2009; 203 (1): 236–242.
Forman JP, Choi H, Curhan GC . Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol 2007; 18 (1): 287–292.
Kaplan NM, Opie LH . Controversies in hypertension. Lancet 2006; 367 (9505): 168–176.
Sari I, Akar S, Pakoz B, Sisman AR, Gurler O, Birlik M et al. Hyperuricemia and its related factors in an urban population, Izmir, Turkey. Rheumatol Int 2009; 29 (8): 869–874.
Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19 (10): 1055–1062.
Liang J, Xue Y, Zou C, Zhang T, Song H, Qi L . Serum uric acid and prehypertension among Chinese adults. J Hypertens 2009; 27 (9): 1761–1765.
Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT et al. Plasma uric acid and the risk of type2 diabetes in a Chinese community. Clin Chem 2008; 54 (2): 310–316.
Lin SD, Tsai DH, Hsu SR . Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc 2006; 69 (11): 512–516.
Lai SW, Ng KC . Which anthropometric indices best predict metabolic disorders in Taiwan? South Med J 2004; 97 (6): 578–582.
Marilda M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38 (5): 1101–1106.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Teng, F., Zhu, R., Zou, C. et al. Interaction between serum uric acid and triglycerides in relation to blood pressure. J Hum Hypertens 25, 686–691 (2011). https://doi.org/10.1038/jhh.2010.112
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2010.112
Keywords
This article is cited by
-
High prevalence and low awareness of hyperuricemia in hypertensive patients among adults aged 50–79 years in Southwest China
BMC Cardiovascular Disorders (2022)
-
Individual and combined association analysis of famine exposure and serum uric acid with hypertension in the mid-aged and older adult: a population-based cross-sectional study
BMC Cardiovascular Disorders (2021)
-
Association between baseline serum uric acid and development of LDL-C level in patients with first acute myocardial infarction
BMC Cardiovascular Disorders (2021)
-
The interaction between serum uric acid and triglycerides level on blood pressure in middle-aged and elderly individuals in China: result from a large national cohort study
BMC Cardiovascular Disorders (2020)
-
Age-differential association between serum uric acid and incident hypertension
Hypertension Research (2019)